Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of ENU dosage on mouse strains.
Justice MJ, Carpenter DA, Favor J, Neuhauser-Klaus A, Hrabé de Angelis M, Soewarto D, Moser A, Cordes S, Miller D, Chapman V, Weber JS, Rinchik EM, Hunsicker PR, Russell WL, Bode VC. Justice MJ, et al. Among authors: weber js. Mamm Genome. 2000 Jul;11(7):484-8. doi: 10.1007/s003350010094. Mamm Genome. 2000. PMID: 10886010
Mouse ENU mutagenesis.
Justice MJ, Noveroske JK, Weber JS, Zheng B, Bradley A. Justice MJ, et al. Among authors: weber js. Hum Mol Genet. 1999;8(10):1955-63. doi: 10.1093/hmg/8.10.1955. Hum Mol Genet. 1999. PMID: 10469849 Review.
The mutagenic action of N-ethyl-N-nitrosourea in the mouse.
Noveroske JK, Weber JS, Justice MJ. Noveroske JK, et al. Among authors: weber js. Mamm Genome. 2000 Jul;11(7):478-83. doi: 10.1007/s003350010093. Mamm Genome. 2000. PMID: 10886009 Review. No abstract available.
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells.
Wang K, Coutifaris P, Brocks D, Wang G, Azar T, Solis S, Nandi A, Anderson S, Han N, Manne S, Kiner E, Sachar C, Lucas M, George S, Yan PK, Kier MW, Laughlin AI, Kothari S, Giles J, Mathew D, Ghinnagow R, Alanio C, Flowers A, Xu W, Tenney DJ, Xu X, Amaravadi RK, Karakousis GC, Schuchter LM, Buggert M, Oldridge D, Minn AJ, Blank C, Weber JS, Mitchell TC, Farwell MD, Herati RS, Huang AC. Wang K, et al. Among authors: weber js. Cancer Cell. 2024 Sep 9;42(9):1582-1597.e10. doi: 10.1016/j.ccell.2024.08.007. Epub 2024 Aug 29. Cancer Cell. 2024. PMID: 39214097
Tyrosine-protein kinase SYK-related gene signature in baseline immune cells associated with adjuvant immunotherapy-induced immune-related adverse events in melanoma.
Monson KR, Ferguson R, Handzlik JE, Xiong J, Dagayev S, Morales L, Chat V, Bunis A, Sreenivasaiah C, Dolfi S, Tenney DJ, Shao Y, Osman I, Weber JS, Kirchhoff T. Monson KR, et al. Among authors: weber js. Clin Cancer Res. 2024 Aug 8. doi: 10.1158/1078-0432.CCR-24-0900. Online ahead of print. Clin Cancer Res. 2024. PMID: 39115425
T Cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination With Pembrolizumab in the Phase 1 KEYNOTE-603 Study.
Gainor JF, Patel MR, Weber JS, Gutierrez M, Bauman JE, Clarke JM, Julian R, Scott AJ, Geiger JL, Kirtane K, Robert-Tissot C, Coder B, Tasneem M, Sun J, Zheng W, Gerbereux L, Laino A, Porichis F, Russella Pollard J, Hou P, Sehgal V, Chen X, Morrissey M, Daghestani HN, Feldman I, Srinivasan L, Frederick JP, Brown M, Aanur P, Meehan R, Burris HA. Gainor JF, et al. Among authors: weber js. Cancer Discov. 2024 Aug 8. doi: 10.1158/2159-8290.CD-24-0158. Online ahead of print. Cancer Discov. 2024. PMID: 39115419
261 results